Company / Gross Profit
LeMaitre Vascular Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$178.5M
FY2025
5-year range
$79.9M / $178.5M
FY2021-FY2025
Trend
+18.3%
vs FY2024
Sector context
#80 of 100
Health Care
What the data says
LeMaitre Vascular's gross profit of $179M is lower than 80% of companies in the Health Care sector (FY2025). Gross Profit has increased for 8 consecutive years, from $54M in FY2017 to $179M in FY2025.
Based on SEC 10-K filings.
$179M in FY2025 with a 5-year CAGR of +19.3%.
Improved from $127M to $179M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +28.3%
- 5-Year CAGR
- +19.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 100This company $178.5M Sector average $1.8B
▼
-90.2% below sector average
Key checks
Key Insights
- LeMaitre Vascular's gross profit has grown for 8 consecutive years.
- 5-year CAGR of +19.3%, indicating consistent growth.
- In FY2025, gross profit increased 18.3% year-over-year.
- Ranks #80 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $178.5M | +18.3% |
| FY2024 | $150.9M | +18.8% |
| FY2023 | $127.0M | +50.1% |
| FY2022 | $84.6M | +6.0% |
| FY2021 | $79.9M | +8.0% |
| FY2020 | $73.9M | +4.6% |
| FY2019 | $70.7M | +12.3% |
| FY2018 | $62.9M | +16.2% |
| FY2017 | $54.2M | -13.9% |
| FY2016 | $62.9M | +39.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026